REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 59 filers reported holding REGULUS THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $97,000 | -70.2% | 492,878 | 0.0% | 0.01% | -69.7% |
| Q2 2018 | $325,000 | -8.2% | 492,878 | 0.0% | 0.03% | -25.0% |
| Q1 2018 | $354,000 | -31.0% | 492,878 | 0.0% | 0.04% | -36.2% |
| Q4 2017 | $513,000 | -29.2% | 492,878 | -15.0% | 0.07% | -25.8% |
| Q3 2017 | $725,000 | +23.9% | 580,000 | -2.3% | 0.09% | +10.7% |
| Q2 2017 | $585,000 | -40.2% | 593,629 | 0.0% | 0.08% | -45.8% |
| Q1 2017 | $979,000 | -7.0% | 593,629 | +26.8% | 0.16% | -23.3% |
| Q4 2016 | $1,053,000 | -99.9% | 468,175 | +56.1% | 0.20% | +28.7% |
| Q3 2016 | $990,000,000 | +97726.1% | 300,000 | -14.3% | 0.16% | -12.8% |
| Q2 2016 | $1,012,000 | -27.0% | 350,000 | +75.0% | 0.18% | -34.5% |
| Q1 2016 | $1,386,000 | -20.5% | 200,000 | 0.0% | 0.28% | +4.2% |
| Q4 2015 | $1,744,000 | +33.3% | 200,000 | 0.0% | 0.26% | +26.3% |
| Q3 2015 | $1,308,000 | – | 200,000 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 327,350 | $943,000 | 0.99% |
| DAFNA Capital Management LLC | 421,500 | $1,218,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 350,000 | $1,012,000 | 0.18% |
| BOURGEON CAPITAL MANAGEMENT LLC | 70,704 | $204,000 | 0.13% |
| Piermont Capital Management Inc. | 151,924 | $439,000 | 0.11% |
| Virtus ETF Advisers LLC | 46,269 | $134,000 | 0.10% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 389,144 | $1,124,000 | 0.08% |
| GLOBEFLEX CAPITAL L P | 80,637 | $233,000 | 0.06% |
| South Dakota Investment Council | 900,000 | $2,601,000 | 0.06% |
| FOX RUN MANAGEMENT, L.L.C. | 33,100 | $96,000 | 0.05% |